Previous Close | 44.69 |
Open | 44.97 |
Bid | 45.42 x 200 |
Ask | 45.67 x 100 |
Day's Range | 44.95 - 45.53 |
52 Week Range | 32.69 - 52.69 |
Volume | |
Avg. Volume | 109,777 |
Market Cap | 908.314M |
Beta (5Y Monthly) | 0.71 |
PE Ratio (TTM) | 87.40 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.24 (0.53%) |
Ex-Dividend Date | Apr 26, 2024 |
1y Target Est | N/A |
LANCASTER, Calif., April 04, 2024--Simulations Plus announced the US FDA has again renewed licenses to its DILIsym QST software to support informed decision-making in drug approvals.
LANCASTER, Calif., April 03, 2024--Simulations Plus today reported earnings for its second quarter of fiscal year 2024. Total revenue for the quarter increased 16% to $18.3 million.
LANCASTER, Calif., March 20, 2024--Simulations Plus will hold a conference call to discuss the Company's 2nd quarter FY24 financial results on Wed, April 3, 2024, at 5pm EDT.